Skip to main content
OpenTrials
Completed

NCT Number: NCT04107857

Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program

The goal of this quality improvement program is to implement, evaluate, and sustain an evidence-based smoking cessation treatment program with a population-based approach so that all patients at the Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, and satellite locations receive assessment of smoking and all smokers receive treatment support.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Health Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Patients seen at Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, or any of the satellite locations

Exclusion criteria

-None

Treatment and study plan

ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer

Behavioral
  • Brief advise to quit smoking
  • Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov

ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer

Behavioral

-Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study)

Data Driven Feedback reports

Behavioral

-Feedback reports will be based on data

Primary outcomes

  1. Clinic level percentage of patients receiving brief counseling

    Time frame: From 6 months pre-intervention through 6 months post-intervention

  2. Clinic level percentage of smokers offered referral to additional counseling

    Time frame: From 6 months pre-intervention through 6 months post-intervention

  3. Clinic level percentage of smokers offered medication

    Time frame: From 6 months pre-intervention through 6 months post-intervention

Secondary outcomes

  1. Clinic level percentage of patients receiving brief counseling

    Time frame: Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

  2. Clinic level percentage of smokers offered referral to additional counseling

    Time frame: Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

  3. Clinic level percentage of smokers offered medication

    Time frame: Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

  4. Clinic level percentage of smokers receiving smoking assessment

    Time frame: Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

  5. Clinic level percentage of smokers receiving cessation medication

    Time frame: Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

  6. Number of patients who have abstained from smoking

    Time frame: Estimated to be 6 months post-intervention

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Official study title

Electronic Health Record-Enabled Evidence-based Smoking Cessation Quality Improvement Program

Important dates

Study start
2019
Primary completion
2020
Study completion
2024
First posted
Sep 27, 2019
Registry last updated
Dec 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.